Latent Mycobacterium tuberculosis infection.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  New England Journal of Medicine

• Publication date

  2015-05-27

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMra1405427PMID 26017823
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The n e w e n g l a n d j o u r n a l of m e d i c i n e A Trial of Mass Isoniazid Preventive Therapy for Tuberculosis Control

  2016cited by this paper
• Treatment for preventing tuberculosis in children and adolescents: a randomized clinical trial of a 3-month, 12-dose regimen of a combination of rifapentine and isoniazid.

  2015cited by this paper
• Long-term protection from isoniazid preventive therapy for tuberculosis in HIV-infected patients in a medium-burden tuberculosis setting: the TB/HIV in Rio (THRio) study.

  2015cited by this paper
• Latent tuberculous infection in the United States and Canada: who completes treatment and why?

  2015cited by this paper
• Treatment of latent tuberculosis infection: a network meta-analysis.

  2014cited by this paper
• Treatment for LTBI in contacts of MDR-TB patients, Federated States of Micronesia, 2009-2012.

  2014cited by this paper
• Isoniazid plus antiretroviral therapy to prevent tuberculosis: a randomised double-blind, placebo-controlled trial.

  2014cited by this paper
• Allele-Specific Induction of IL-1β Expression by C/EBPβ and PU.1 Contributes to Increased Tuberculosis Susceptibility

  2014cited by this paper
• Infections Caused by Mycobacterium tuberculosis in Recipients of Hematopoietic Stem Cell Transplantation

  2014cited by this paper
• Diagnostic Accuracy of Chest Radiography for the Diagnosis of Tuberculosis (TB) and Its Role in the Detection of Latent TB Infection: a Systematic Review

  2014cited by this paper
• Outcome of Latent Tuberculosis Infection in Solid Organ Transplant Recipients Over a 10-Year Period

  2014cited by this paper
• Gamma Interferon Release Assays for Detection of Mycobacterium tuberculosis Infection

  2014cited by this paper
• A trial of mass isoniazid preventive therapy for tuberculosis control.

  2014cited by this paper
• A new unifying theory of the pathogenesis of tuberculosis.

  2014cited by this paper
• Beyond the IFN-&ggr; horizon: biomarkers for immunodiagnosis of infection with Mycobacterium tuberculosis

  2014cited by this paper
• First national tuberculin survey in Viet Nam: characteristics and association with tuberculosis prevalence.

  2013cited by this paper
• Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.

  2013cited by this paper
• Preventive therapy for child contacts of multidrug-resistant tuberculosis: a prospective cohort study.

  2013cited by this paper
• Estimated rate of reactivation of latent tuberculosis infection in the United States, overall and by population subgroup.

  2013cited by this paper
• The immune response in tuberculosis.

  2013cited by this paper
• TB or Not TB: That Is No Longer the Question

  2013cited by this paper
• Tuberculin skin test conversion among HIV patients on antiretroviral therapy in Uganda.

  2013cited by this paper
• Prospects for tuberculosis elimination.

  2013cited by this paper
• Cost-effectiveness of a 12-dose regimen for treating latent tuberculous infection in the United States.

  2013cited by this paper
• Improved Outcome of Surgical Pulmonary Embolectomy in a Referral Hospital Setting

  2012cited by this paper
• Predictive value of interferon-γ release assays for incident active tuberculosis: a systematic review and meta-analysis.

  2012cited by this paper
• Factors Associated with the Performance of a Blood-Based Interferon-γ Release Assay in Diagnosing Tuberculosis

  2012cited by this paper
• Single-step QuantiFERON screening of adult contacts: a prospective cohort study of tuberculosis risk

  2012cited by this paper
• Predictive value of interferon-γ release assays and tuberculin skin testing for progression from latent TB infection to disease state: a meta-analysis.

  2012cited by this paper
• Development of a Standardized Screening Rule for Tuberculosis in People Living with HIV in Resource-Constrained Settings: Individual Participant Data Meta-analysis of Observational Studies

  2011cited by this paper
• Use of Interferon‐Gamma Release Assay for Latent Tuberculosis Infection Screening in Older Adults Exposed to Tuberculosis in a Nursing Home

  2011cited by this paper
• Three months of rifapentine and isoniazid for latent tuberculosis infection.

  2011cited by this paper
• Incipient and subclinical tuberculosis: defining early disease states in the context of host immune response.

  2011cited by this paper
• New regimens to prevent tuberculosis in adults with HIV infection.

  2011cited by this paper
• Clinical practice. Latent tuberculosis infection in the United States.

  2011cited by this paper
• Latent TB infection treatment acceptance and completion in the United States and Canada.

  2010cited by this paper
• Tuberculosis Incidence in Prisons: A Systematic Review

  2010cited by this paper
• LTBI: latent tuberculosis infection or lasting immune responses to M. tuberculosis? A TBNET consensus statement

  2009cited by this paper
• Annual Risk of Tuberculous Infection Using Different Methods in Communities with a High Prevalence of TB and HIV in Zambia and South Africa

  2009cited by this paper
• Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial

  2009cited by this paper
• Adverse Events with 4 Months of Rifampin Therapy or 9 Months of Isoniazid Therapy for Latent Tuberculosis Infection

  2008cited by this paper
• Adherence to treatment for latent tuberculosis infection: systematic review of studies in the US and Canada.

  2008cited by this paper
• Tuberculosis reactivation during immunosuppressive therapy in rheumatic diseases: diagnostic and therapeutic strategies

  2008cited by this paper
• Glucocorticoid use, other associated factors, and the risk of tuberculosis.

  2006cited by this paper
• National survey to measure rates of liver injury, hospitalization, and death associated with rifampin and pyrazinamide for latent tuberculosis infection.

  2005cited by this paper
• Treatment of latent tuberculosis infection in HIV infected persons.

  2004cited by this paper
• World Health Organization,

  2003cited by this paper
• The growing burden of tuberculosis: global trends and interactions with the HIV epidemic.

  2003cited by this paper
• HIV infection and silicosis: the impact of two potent risk factors on the incidence of mycobacterial disease in South African miners

  2000cited by this paper
• Tuberculosis in the homeless. A prospective study.

  2000cited by this paper
• How much isoniazid is needed for prevention of tuberculosis among immunocompetent adults?

  1999cited by this paper
• Isoniazid for preventing tuberculosis in non-HIV infected persons.

  1999cited by this paper
• Estimation of the annual risk of tuberculosis infection for white men in the United States.

  1997cited by this paper
• Prospective study of human immunodeficiency virus infection and pregnancy outcomes in intravenous drug users.

  1989cited by this paper
• A prospective study of the risk of tuberculosis among intravenous drug users with human immunodeficiency virus infection.

  1989cited by this paper
• The prognosis of a positive tuberculin reaction in childhood and adolescence.

  1974cited by this paper
• Osler's Influence in the War Against Tuberculosis (The Fifth Osler Oration).

  1942cited by this paper

• Burden of Latent Tuberculosis Infection (LTBI) Among Patients Attending a Tertiary Care Hospital in Eastern India: A Descriptive Study

  2026cites this paper
• Disparities in testing for latent tuberculosis infection in a large US integrated healthcare system.

  2026cites this paper
• The cascade of care for latent tuberculosis infection in Malaysia: a cohort analysis.

  2026cites this paper
• The implementation of tuberculosis preventive therapy in HIV care clinics in Africa, Asia and Latin America: a multiregional site survey

  2026cites this paper
• Recommendations on the Diagnosis and Treatment of Tuberculosis Infection: SEPAR/SEIMC/Spanish Ministry of Health Consensus Statement.

  2026cites this paper
• Evaluation of a combined tuberculosis case-finding, treatment and prevention strategy in Thailand: protocol for a pragmatic phase IV stepped-wedge cluster-randomised trial, the CaPThai study.

  2026cites this paper
• Estimating the global burden of viable Mycobacterium tuberculosis infection: A mathematical modelling study

  2026cites this paper
• Expression and clinical value of key m6A RNA modification regulators in tuberculosis

  2026cites this paper
• An ultrasensitive electrochemical RNA biosensor for mycobacterium tuberculosis detection with hyperbranched primer exchange reaction cascade amplification and sDNA@Au@Pt@UiO-66-NH2 nanozymes

  2025cites this paper
• Exposure Time to a Tuberculosis Index Case as a Marker of Infection in Immigrant Populations

  2025cites this paper
• Enhancing Antituberculosis Treatment Nanoparticles Encapsulated with Catalase and Levofloxacin Under Ultrasound Stimulation: A 3D Spheroid Study.

  2025cites this paper
• Four months daily rifampicin versus three months daily rifampicin/isoniazid for the treatment of tuberculosis infection in asylum seekers: a randomized controlled trial.

  2025cites this paper
• Manejos diagnóstico y terapéutico en un contagio tuberculoso

  2025cites this paper
• Efficacy of Isoniazid–Rifampicin Preventive Therapy in Adolescent Contacts in School Outbreaks: A Retrospective Cohort Study in Eastern China

  2025cites this paper
• 5-Iodotubercidin: A Novel Anti-Tuberculosis Lead with Promising Antimicrobial Activity, Pharmacokinetics, and Safety Profile.

  2025cites this paper
• NIR-II aggregation-induced emission nanoparticles camouflaged with preactivated macrophage membranes for phototheranostics of pulmonary tuberculosis

  2025cites this paper
• Resistance to tuberculin skin test/interferon-gamma release assay conversion among highly TB exposed, HIV infected goldminers in South Africa

  2025cites this paper
• Adverse events of tuberculosis preventive therapy among individuals with latent tuberculosis infection: A nationwide cohort study in South Korea.

  2025cites this paper
• Multiplexed cytokine profiling identifies diagnostic signatures for latent tuberculosis and reactivation risk stratification

  2025cites this paper
• Functional and mechanistic insights into the stealth protein full-length CpsY is conducive to understanding immune evasion mechanisms by Mycobacterium tuberculosis.

  2025cites this paper
• Diagnostic Challenges of Tuberculous Meningitis Initially Presenting as Otomastoiditis

  2025influential citation
• Effect of Bacillus Calmette-Guérin vaccination against Mycobacterium tuberculosis infection in children: an updated systematic review and meta-analysis.

  2025cites this paper
• Safety, efficacy and feasibility of preventive treatment for drug-resistant tuberculosis with moxifloxacin or bedaquiline

  2025cites this paper
• Cost-effectiveness of diabetes screening and diagnosis services for people with TB in the Philippines.

  2025cites this paper
• Bayesian phylodynamic inference of population dynamics with dormancy

  2025cites this paper
• Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli

  2025cites this paper
• Effect of BCG vaccination on the progression of latent tuberculosis infection to active disease in contacts: a systematic review and meta-analysis

  2025cites this paper
• Comparison Between Behçet’s Uveitis Patients with Immunologically Positive and Immunologically Negative Tuberculosis Test

  2025cites this paper
• Acceptance of preventive therapy for latent tuberculosis infection in Chinese children and adolescents: a systematic review and meta-analysis

  2025cites this paper
• Identification of risk factors for latent tuberculosis infection in Xinjiang using machine learning

  2025cites this paper
• Impact of Latent Tuberculosis Infection and T-SPOT.TB Dynamics Alterations on Prognosis in Advanced NSCLC Treated With ICIs——IPTW-Based Retrospective Study

  2025influential citation
• The effect of latent Mycobacterium tuberculosis infection on ovarian reserve and pregnancy outcomes among infertile women in China

  2025cites this paper
• A predictive model for evaluating the risk of latent tuberculosis relapse via machine learning

  2025cites this paper
• Prevalence and factors associated with tuberculosis infection (TBI) among residents of a monastery situated in a high-TB burden area: A cross-sectional study, Sikkim, India

  2025cites this paper
• Association between Blood Metabolites and Pulmonary Tuberculosis: A Mendelian Randomization Analysis

  2025cites this paper
• Comprehensive review and reflective evaluation of cell therapies for tuberculosis

  2025cites this paper
• Analysis of Lymphocyte Immunologic Indexes in the Early Diagnosis of Active Pulmonary Tuberculosis of Adolescents in China

  2025cites this paper
• Impact of Latent Tuberculosis Infection on Ovarian Reserve and In Vitro Fertilization or Intracytoplasmic Sperm Injection Outcomes: A Retrospective Cohort Study with Propensity Score Matching

  2025cites this paper
• The impact of air pollution on active tuberculosis development from latent tuberculosis infection in rural China: 10-year follow-up of a cohort study

  2025cites this paper
• Association of dietary caffeine intake and metabolites in the urine of individuals with latent tuberculosis infection: a cross-sectional study

  2025cites this paper
• Mycobacterium spp. exposure, childhood vaccinations, and early childhood brain and CNS cancers

  2025cites this paper
• Pharmacogenetics of plasma dolutegravir exposure during 1-month rifapentine/isoniazid treatment of latent tuberculosis

  2025cites this paper
• Brazilian recommendations for the management of tuberculosis infection in immune-mediated inflammatory diseases

  2025cites this paper
• Cost-effectiveness analysis comparing QuantiFERON test and tuberculin skin test for the diagnosis of latent tuberculosis infection in immunocompetent children under 15 years of age in Colombia

  2025cites this paper
• Prognosis of patients diagnosed with latent tuberculosis infection at dialysis initiation

  2025cites this paper
• Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts

  2025cites this paper
• Approcci diagnostici e terapeutici di fronte a un contagio tubercolare

  2025cites this paper
• Effectiveness of tuberculosis preventive treatment in patients with rheumatic diseases: a global systematic review and meta-analysis

  2025cites this paper
• The association between triglyceride-glucose index and related parameters and risk of tuberculosis infection in American adults under different glucose metabolic states: a cross-sectional study

  2025cites this paper
• Disseminated Tuberculosis Driving Secondary Haemophagocytic Lymphohistiocytosis Following Adalimumab and Treatment for Latent Tuberculosis.

  2025cites this paper
• Factors associated with acceptance of preventive treatment among college students with latent tuberculosis infection in Shandong, China.

  2025cites this paper
• Unveiling the silent defenders: mycobacterial stress sensors at the forefront to combat tuberculosis

  2025cites this paper
• Therapeutic vaccination with the Ag85B-Rv2660c-MPT70 fusion protein enhances Mycobacterium tuberculosis H37Ra clearance in post-exposure mice

  2025cites this paper
• Bayesian phylodynamic inference of population dynamics with dormancy

  2025cites this paper
• Adherence to treatment for tuberculosis infection in children using a comprehensive care strategy: a prospective cohort study with a historical control group

  2025cites this paper
• Proteomic analysis of plasma unravels dynamic pathways and potential biomarkers indicating disease stages following Mtb infection

  2025cites this paper
• Burden of tuberculosis in Eastern Africa region from 1990–2021: A systematic analysis for the Global Burden of Disease 2021 Study

  2025cites this paper
• Circulating Aryl Hydrocarbon Receptor Is Associated with Latent Tuberculosis Infection in Patients with Type 2 Diabetes

  2025cites this paper
• Effectiveness of centralized hospitalization treatment on transmission in household contacts of pulmonary tuberculosis patients: a contact-traced study

  2025cites this paper
• Association between latent tuberculosis infection and assisted reproductive outcomes: a systematic review and meta-analysis

  2025cites this paper
• Risk Factors Associated With Tuberculosis Infection Among Household Contacts of Patients With Microbiologically Confirmed Pulmonary Tuberculosis in 3 High Tuberculosis Burden Countries

  2025cites this paper
• Identification of Gene Expression Biomarkers Predictive of Latent Tuberculosis Infection Using Machine Learning Approaches

  2025cites this paper
• A randomised crossover clinical trial of the efficacy of an ultrasonic cleaner combined with a denture cleanser on the microbiome on removable dentures among community-dwelling older adults.

  2025cites this paper
• Retrospective evaluation of active tuberculosis cases in terms of chemoprophylaxis indication: A cross-sectional study

  2025cites this paper
• Impact of detection rate and preventive treatment of latent tuberculosis infection on the future burden of tuberculosis among students in shanghai: a predictive study using Markov modeling

  2025cites this paper
• Mycobacterium tuberculosis infection following polyacrylamide hydrogel (Amazingel) breast augmentation: A case report and literature review

  2025cites this paper
• Body Mass Index and Incident Tuberculosis in Close Tuberculosis Contacts.

  2025cites this paper
• Discovering Biomarkers for Asymptomatic Tuberculosis via Olink Proteomics and Machine Learning.

  2025cites this paper
• A human YEATS4 variant confers resistance to TST and IGRA conversion despite Mycobacterium tuberculosis exposure

  2025cites this paper
• The Study of Associated Factors for Non-Tuberculous Mycobacterial Pulmonary Disease Compared to Pulmonary Tuberculosis: A Propensity Score Matching Analysis

  2024cites this paper
• Systemic and ocular outcomes in TB-immunoreactive patients receiving immunomodulatory therapy for non-infectious uveitis: a case-control study

  2024cites this paper
• Imaging Spectrum in Pulmonary Tuberculosis

  2024cites this paper
• Identification of MORN3 and LLGL2 as novel diagnostic biomarkers for latent tuberculosis infection using machine learning strategies and experimental verification

  2024cites this paper
• Optimizing the cascade of prevention to protect people from tuberculosis: A potential game changer for reducing global tuberculosis incidence

  2024cites this paper
• One-month daily and three-month weekly rifapentine plus isoniazid are comparable in completion rate and safety for latent tuberculosis infection in non-HIV Population: A randomized controlled trial.

  2024cites this paper
• Investigating the Diagnostic and Therapeutic Potential of a T Cell Receptor (TCR)-like single Domain Antibody (sDAb)-Human IgG1 Antibody against Heat Shock Protein (HSP) 16KDa/HLA-A2 for Latent Tuberculosis

  2024cites this paper
• Adherence to Preventive Treatment for Latent Tuberculosis Infection in Close Contacts of Pulmonary Tuberculosis Patients: A Cluster-Randomized Controlled Trial in China.

  2024cites this paper
• Dynamic tuberculosis screening for healthcare employees

  2024cites this paper
• Aerosol sources and transport paths co-control the atmospheric bacterial diversity over the coastal East China Sea.

  2024cites this paper
• Advanced Therapeutic Interventions Targeting Mycobacterium Tuberculosis.

  2024cites this paper
• The rs11684747 and rs55790676 SNPs of ADAM17 influence tuberculosis susceptibility and plasma levels of TNF, TNFR1, and TNFR2

  2024cites this paper
• The function of CD36 in Mycobacterium tuberculosis infection

  2024cites this paper
• Mixed methods study on latent tuberculosis among agate stone workers and advocacy for testing silica dust exposed individuals in India

  2024cites this paper
• Evaluating Treatment Outcomes and Tuberculosis Infection Risks: A Comparative Study of Centralized Hospitalization vs. Home-Based Treatment

  2024cites this paper
• Flow cytometry-based method using diversity of cytokine production differentiates between Mycobacterium tuberculosis infection and disease.

  2024cites this paper
• Lipid-Laden Macrophages in Pulmonary Diseases

  2024cites this paper
• Cost-effectiveness of diagnostic tools and strategies for the screening and diagnosis of tuberculosis disease and infection: a scoping review

  2024cites this paper
• Factors associated with incomplete tuberculosis preventive treatment: a retrospective analysis of six-years programmatic data in Cambodia

  2024cites this paper
• Mycobacterium tuberculosis is less likely to acquire pathogenic mutations during latent infection than during active disease

  2024cites this paper
• Overcoming barriers to scaling up tuberculosis preventive treatment for household contacts.

  2024cites this paper
• HLA-DPB1*05:01 and HLA-A*11:01 Is Associated with Adverse Drug Reactions to Isoniazid and Rifampin for Treatment of Latent Tuberculosis Infection in South Korea

  2024cites this paper
• Associations between mixed exposure to phthalates and latent tuberculosis infection among the general U.S. population from NHANES 2011–2012

  2024cites this paper
• Mathematical modeling of age-specific intervention strategies for latent tuberculosis infection

  2024cites this paper
• Dual-mode sensing of Mycobacterium tuberculosis with DNA-functionalized gold nanoparticles and asymmetric RPA-triggered PAM-free CRISPR system

  2024cites this paper
• Visual detection of Mycobacterium tuberculosis in exhaled breath using N95 enrichment respirator, RPA, and lateral flow assay.

  2024cites this paper
• Alterations in purine and pyrimidine metabolism associated with latent tuberculosis infection: insights from gut microbiome and metabolomics analyses

  2024cites this paper
• Tuberculin skin test and Interferon-gamma release assay agreement, and associated factors with latent tuberculosis infection, in medical and nursing students in Bandung, Indonesia

  2024cites this paper
• Influenza and the risk of active tuberculosis occurrence among individuals with latent tuberculosis infection: A national cohort study in South Korea (2015-2020).

  2024cites this paper
• IGRA Testing in Suriname, an Intermediate Tuberculosis Incidence Country

  2024cites this paper
• Mycobacterium tuberculosis resisters despite HIV exhibit activated T cells and macrophages in their pulmonary alveoli

  2024cites this paper